Sun Pharmaceutical Industries Share Price Today - Live Blog for September 05, 2025

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.10% decline, and it currently trades at ₹1,592.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Sun Pharmaceutical Industries Ltd witnessed a -0.11% decrease in its share price, and it is currently trading at ₹1,593.75. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

With a remarkable 0.02% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,595.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.6000, while the industry's PE ratio is 34.7238.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.03% increase. Presently, it is actively trading at ₹1,594.65.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.02% increase in its share price and is currently trading at ₹1,594.10. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.14%, reaching a current market price of ₹1,593.85. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.10%. At this moment, it's actively trading at ₹1,596.00, presenting an enticing opportunity for those in the market.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.13%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,594.00 per share.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.08%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,592.00 per share.

Demonstrating a commendable 0.36% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,590.75. In terms of valuation, the stock maintains a PE ratio of 36.6000, while the industry PE ratio stands at 34.7238.

Sun Pharmaceutical Industries Ltd share price has declined by -0.02%, and it's currently trading at ₹1,585.15. The stock maintains a PE of 36.6000, while the industry PE is 34.7238, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.08%, reaching the current market price of ₹1,585.40. This surge is indicative of the stock's recent positive performance.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.30% drop, and it's now trading at ₹1,581.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.30% drop, and it's now trading at ₹1,581.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.08% boost, with the current market value at ₹1,586.20 per share. This surge has not gone unnoticed by investors.

Sun Pharmaceutical Industries Ltd shares experienced a -0.31% reduction, with the current market price at ₹1,586.15. Investors are carefully considering their positions and seeking insights into the stock's future performance.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.50% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,591.40 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares saw a -0.15% decrease, reaching a current market price of ₹1,583.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.02%, reaching a current market price of ₹1,586.35. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.26%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,584.85, and market participants are assessing the implications. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.17% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,589.10 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

After a -0.17% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,586.45. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.40%, reaching the current market price of ₹1,592.10. This development underscores the stock's growing popularity.

With a remarkable 0.03% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,584.90. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.6000, while the industry's PE ratio is 34.7238.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.41% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,584.45 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

With a -0.15% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,580.00. The stock is currently trading at a PE of 36.6000, while the industry PE is 34.7238, prompting investors to assess its value proposition.